Tactile Systems Technology (NASDAQ:TCMD) Upgraded to “Strong-Buy” at StockNews.com

StockNews.com upgraded shares of Tactile Systems Technology (NASDAQ:TCMDFree Report) from a buy rating to a strong-buy rating in a research note issued to investors on Friday.

Other research analysts have also issued reports about the company. B. Riley initiated coverage on Tactile Systems Technology in a report on Thursday, September 26th. They set a “buy” rating and a $23.00 target price on the stock. Oppenheimer cut shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. Finally, BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th.

View Our Latest Stock Report on TCMD

Tactile Systems Technology Trading Up 0.3 %

Tactile Systems Technology stock opened at $17.00 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.80 and a current ratio of 4.37. The stock has a 50-day simple moving average of $16.32 and a 200 day simple moving average of $14.03. The stock has a market capitalization of $407.95 million, a P/E ratio of 26.15 and a beta of 1.20. Tactile Systems Technology has a 52 week low of $11.12 and a 52 week high of $21.10.

Hedge Funds Weigh In On Tactile Systems Technology

A number of hedge funds have recently added to or reduced their stakes in TCMD. Arcadia Investment Management Corp MI acquired a new position in Tactile Systems Technology in the third quarter valued at about $29,000. Gladius Capital Management LP bought a new position in Tactile Systems Technology in the 3rd quarter valued at about $44,000. Quarry LP acquired a new position in shares of Tactile Systems Technology in the 2nd quarter valued at approximately $46,000. SG Americas Securities LLC bought a new stake in shares of Tactile Systems Technology during the 3rd quarter worth approximately $156,000. Finally, Magnetar Financial LLC acquired a new stake in shares of Tactile Systems Technology during the 2nd quarter worth approximately $130,000. Institutional investors own 83.43% of the company’s stock.

About Tactile Systems Technology

(Get Free Report)

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.

Featured Stories

Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.